Overview and Scope
Digital biomanufacturing is the use of digital technologies and advanced analytics in the field of biomanufacturing. It blends data-driven decision-making, automation, and sophisticated manufacturing technology to increase process efficiency and expedite innovation in the biomanufacturing business.
Sizing and Forecast
The digital biomanufacturing market size has grown rapidly in recent years. It will grow from $18.87 billion in 2023 to $21.57 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing complexity of biopharmaceuticals, rise in personalized medicine, demand for cost-effective production, bioprocess optimization, quality control and regulatory compliance.
The digital biomanufacturing market size is expected to see rapid growth in the next few years. It will grow to $35.01 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to blockchain for supply chain transparency, advanced process control (APC) systems, emphasis on sustainability, interconnected biomanufacturing ecosystems, biomanufacturing in emerging markets. Major trends in the forecast period include integration of artificial intelligence (AI), digital twins for bioprocessing, advancements in biotechnology, Industry 4.0 integration, real-time monitoring and control.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report
The digital biomanufacturing market covered in this report is segmented –
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes
North America was the largest region in the digital biomanufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10828&type=smp
Major Driver Impacting Market Growth
The growing demand for biologics is expected to propel the growth of the digital biomanufacturing market going forward. Biologicals are a vast class of pharmaceuticals that include vaccines, growth factors, immunological modulators, monoclonal antibodies, and drugs produced from human blood and plasma. Digital biomanufacturing is used to enhance biologics production by optimizing processes, quality control, lowering costs, and shortening production time, which helps producers to embrace data-driven methodologies and advanced technology to satisfy rising biologics demand more efficiently and sustainably. For instance, in January 2021, according to US Food and Drug Administration, a US-based federal agency of the Department of Health and human services, the Center for drug evaluation and Research (CDER), authorized 37 innovative pharmaceuticals in 2022, either as new molecular entities (NMEs) through new drug applications (NDAs) or as new therapeutic biological products through biologics license applications (BLAs). Further, according to the National Library of Medicine, a US-based center of biomedical informatics and computational biology, there were 14 biologics approvals and authorization of 36 small molecules in 2021. Therefore, the growing demand for biologics is driving the digital biomanufacturing market.
Key Industry Players
Major companies operating in the digital biomanufacturing market report are Sanofi SA, Thermo Fisher Scientific Inc., Honeywell International Inc., 3M Company, SAP SE, Danaher Corporation, ABB AG, Siemens Healthineers AG, Emerson Electric Co, GE HealthCare Technologies Inc., Atos SE, Agilent Technologies Inc., Cytiva Europe GmbH, Lonza Group AG, Dassault Systèmes SE, Sartorius AG, BioMérieux, Donaldson Company Inc., Pall Corporation, Eppendorf AG, Xenon Pharmaceuticals Inc., Symphony Innovation LLC, Koch Membrane Systems Inc., Culture Biosciences Inc., Bota Biosciences Inc., Xenex Laboratories Inc., Shimadzu Corporation, e-MSion, Exponential Genomics Inc., Immersciobio GmbH
The digital biomanufacturing market report table of contents includes:
1. Executive Summary
2. Digital Biomanufacturing Market Characteristics
3. Digital Biomanufacturing Market Trends And Strategies
4. Digital Biomanufacturing Market – Macro Economic Scenario
5. Global Digital Biomanufacturing Market Size and Growth
…..
32. Global Digital Biomanufacturing Market Competitive Benchmarking
33. Global Digital Biomanufacturing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Digital Biomanufacturing Market
35. Digital Biomanufacturing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
